Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,321,458 papers from all fields of science
Search
Sign In
Create Free Account
CP 31398
Known as:
CP-31,398
, CP-31398
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Pyrimidines
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
A p53-stabilizing agent, CP-31398, induces p21 expression with increased G2/M phase through the YY1 transcription factor in esophageal carcinoma defective of the p53 pathway.
Boya Zhong
,
M. Shingyoji
,
+6 authors
M. Tagawa
American Journal of Cancer Research
2019
Corpus ID: 73439181
Restoration of p53 functions is one of the therapeutic strategies for esophageal carcinoma which is often defective of the p53…
Expand
2016
2016
Targeting cancer stem cells with p53 modulators
Zhan Zhang
,
Ling Liu
,
+5 authors
A. Deleo
OncoTarget
2016
Corpus ID: 8686874
Cancer stem cells (CSC) typically over-express aldehyde dehydrogenase (ALDH). Thus, ALDHbright tumor cells represent targets for…
Expand
2016
2016
Chemoprevention of spontaneous ovarian cancer in the domestic hen
E. Moçka
,
R. A. Stern
,
O. Fletcher
,
K. Anderson
,
J. Petitte
,
P. Mozdziak
Poultry Science
2016
Corpus ID: 4479651
&NA; The hen is an attractive animal model for in vivo testing of agents that thwart ovarian carcinogenesis because ovarian…
Expand
2014
2014
p53 Protein Regulates Hsp90 ATPase Activity and Thereby Wnt Signaling by Modulating Aha1 Expression*
S. Okayama
,
L. Kopelovich
,
+4 authors
K. Subbaramaiah
Journal of Biological Chemistry
2014
Corpus ID: 24805807
Background: The mechanism by which p53, a tumor suppressor gene, regulates Wnt signaling is incompletely understood. Results: p53…
Expand
2013
2013
A compound CP-31398 suppresses excitotoxicity-induced neurodegeneration.
Takeshi Fujiwara
,
Koji Morimoto
Biochemical and Biophysical Research…
2013
Corpus ID: 40221431
Highly Cited
2012
Highly Cited
2012
Autophagy induced by p53-reactivating molecules protects pancreatic cancer cells from apoptosis
Claudia Fiorini
,
M. Menegazzi
,
+6 authors
Massimo Donadelli
Apoptosis
2012
Corpus ID: 2454392
TP53 mutations compromising p53 transcriptional function occur in more than 50 % of human cancers, including pancreatic…
Expand
2012
2012
Pharmacokinetics and tissue and tumor exposure of CP-31398, a p53-stabilizing agent, in rats
I. Kapetanovic
,
M. Muzzio
,
+6 authors
L. Kopelovich
Cancer Chemotherapy and Pharmacology
2012
Corpus ID: 23464201
PurposeCP-31398 (N′-[2-[(E)-2-(4-methoxyphenyl)ethenyl]quinazolin-4-yl]-N,N-dimethylpropane-1,3-diamine hydrochloride) is one of…
Expand
2009
2009
Inhibition of azoxymethane-induced colorectal cancer by CP-31398, a TP53 modulator, alone or in combination with low doses of celecoxib in male F344 rats.
C. Rao
,
V. Steele
,
M. Swamy
,
J. Patlolla
,
S. Guruswamy
,
L. Kopelovich
Cancer Research
2009
Corpus ID: 14566016
Tumor suppressor p53 plays a major role in colorectal cancer development. The present study explores the effects of p53…
Expand
Highly Cited
2004
Highly Cited
2004
CP-31398 Restores DNA-binding Activity to Mutant p53 in Vitro but Does Not Affect p53 Homologs p63 and p73*
M. Demma
,
Serena Wong
,
E. Maxwell
,
B. Dasmahapatra
Journal of Biological Chemistry
2004
Corpus ID: 7531446
The p53 protein plays a major role in the maintenance of genome stability in mammalian cells. Mutations of p53 occur in over 50…
Expand
2003
2003
The p53-stabilizing compound, CP-31398, does not enhance chemosensitivity in human melanoma cells.
Y. Luu
,
Gang Li
Anticancer Research
2003
Corpus ID: 46009846
BACKGROUND Malignant melanoma is a life-threatening disease with a poor prognosis due to its capacity for rapid metastasis and…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE